PEPFAR Data Reveals Concerning Drops in H.I.V. Testing and Care
New figures from the U.S. global AIDS program show significant declines in access to critical H.I.V. services, raising concerns about the pandemic's future trajectory.
A recent report from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) has revealed worrying declines in H.I.V. testing and treatment across the program's partner countries. The data, which tracks progress in the global fight against the H.I.V. pandemic, points to a potential reversal of hard-won gains in combating the disease.
The PEPFAR program, which has been a cornerstone of U.S. global health efforts for nearly two decades, provides life-saving antiretroviral therapy and other critical H.I.V. services to millions of people in low- and middle-income countries. However, the latest figures indicate that the COVID-19 pandemic has had a significant impact on access to these vital interventions.
Source: The New York Times
